Status:
ACTIVE_NOT_RECRUITING
Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening
Lead Sponsor:
Centre Regional de Coordination des Depistages des Cancer - Pays de la Loire
Collaborating Sponsors:
National Cancer Institute, France
Sciensano
Conditions:
Cancer Screening Test
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
The cervical cancer screening coverage remains moderate (60%) in France. The aim of the study is to evaluate the efficacy of two experimental invitation strategies (offer of urine or vaginal self-samp...
Detailed Description
Research question: does the offer of self-sampling kits result in higher attendance to cervical cancer screening compared to sending invitation letters which recommend women to contact a health profes...
Eligibility Criteria
Inclusion
- women aged between 30 and 65 years
- living in the Departments of Mayenne, Vendée and Sarthe (Pays de la Loire, France)
- who have not carried out a screening test (cytology of smear or HPV test) following a letter sent 12 months previously (in 2020 or 2021).
Exclusion
- recent cervical sampling (less than three years old)
- women younger than 30 or older than 65 years
- women who have had a hysterectomy
- women with ongoing follow-up for a cervical lesion
- women who are not members or beneficiaries of a social security system.
Key Trial Info
Start Date :
March 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT05243888
Start Date
March 9 2022
End Date
March 1 2025
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRCDC Pays de la Loire
Angers, France